Overview

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
All
Summary
A pragmatic, single blinded, randomized, controlled non-inferiority trial of Cytisine versus Nicotine Replacement Therapy for continuous abstinence is conducted in the government run primary health hospitals in Mongolia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Loma Linda University
Collaborators:
Mongolian National University of Medical Sciences
Pfizer
Treatments:
Nicotine
Criteria
Inclusion Criteria:

- Seeking smoking cessation treatment

- Ages 18 years or older

- Currently smoking > 5 cigarettes per day

- Willingness to make quit attempt with pharmacotherapy

- Able to provide verbal and written informed consent

- Have telephone access

Exclusion Criteria:

- Pregnancy or currently breastfeeding

- Current users of NRT (patch, gum, lozenge)

- Current users of non_NRT smoking cessation pharmacotherapy

- Enrolled in another smoking cessation program (non-governmental)

- Clinical disorder that contraindicates use of NRT or Cytisine (heart attack, stroke,
severe angina within the past 2 weeks, uncontrolled hypertension, phaeochromocytoma,
severe mental illness)